Prothena Historical Financial Ratios

PRTA Stock  USD 14.53  0.75  5.44%   
Prothena Plc is promptly reporting on over 109 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 7.17, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 0.43 will help investors to properly organize and evaluate Prothena plc financial condition quickly.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.

About Prothena Financial Ratios Analysis

Prothena plcFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Prothena Plc investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Prothena financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Prothena Plc history.

Prothena Plc Financial Ratios Chart

At present, Prothena Plc's PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 28.75, whereas Price To Sales Ratio is forecasted to decline to 20.11.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Prothena plc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Prothena Plc sales, a figure that is much harder to manipulate than other Prothena plc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.
Most ratios from Prothena Plc's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Prothena plc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.At present, Prothena Plc's PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Days Sales Outstanding is expected to grow to 28.75, whereas Price To Sales Ratio is forecasted to decline to 20.11.
 2021 2023 2024 (projected)
Graham Number18.9525.6117.34
Receivables Turnover869.4417.7116.83

Prothena Plc fundamentals Correlations

0.230.720.130.1-0.290.070.230.95-0.32-0.210.14-0.420.280.1-0.260.69-0.020.190.090.150.17-0.2-0.09-0.210.16
0.230.030.880.22-0.23-0.561.00.1-0.23-0.98-0.18-0.270.040.010.350.040.46-0.060.690.17-0.070.160.13-0.98-0.07
0.720.030.06-0.02-0.280.250.030.82-0.30.050.25-0.21-0.06-0.19-0.350.35-0.030.1-0.130.060.08-0.230.010.050.06
0.130.880.060.32-0.18-0.450.880.1-0.17-0.81-0.17-0.16-0.29-0.180.120.060.76-0.250.56-0.05-0.260.350.12-0.81-0.26
0.10.22-0.020.320.46-0.10.220.130.44-0.08-0.390.34-0.250.020.230.020.6-0.250.53-0.22-0.250.16-0.11-0.08-0.26
-0.29-0.23-0.28-0.180.46-0.08-0.23-0.31.00.29-0.690.87-0.20.320.12-0.310.16-0.27-0.01-0.3-0.24-0.170.010.29-0.23
0.07-0.560.25-0.45-0.1-0.08-0.560.27-0.130.570.190.0-0.03-0.21-0.310.43-0.240.12-0.41-0.230.12-0.120.020.570.12
0.231.00.030.880.22-0.23-0.560.1-0.23-0.98-0.18-0.270.040.010.350.040.46-0.060.690.17-0.070.160.13-0.98-0.07
0.950.10.820.10.13-0.30.270.1-0.33-0.040.13-0.340.16-0.14-0.340.730.040.16-0.010.080.14-0.160.0-0.040.13
-0.32-0.23-0.3-0.170.441.0-0.13-0.23-0.330.29-0.670.88-0.20.320.13-0.370.16-0.27-0.01-0.28-0.24-0.160.010.28-0.23
-0.21-0.980.05-0.81-0.080.290.57-0.98-0.040.290.080.37-0.08-0.12-0.31-0.03-0.330.07-0.64-0.160.08-0.1-0.021.00.07
0.14-0.180.25-0.17-0.39-0.690.19-0.180.13-0.670.08-0.6-0.17-0.17-0.280.04-0.35-0.17-0.21-0.18-0.210.14-0.550.08-0.2
-0.42-0.27-0.21-0.160.340.870.0-0.27-0.340.880.37-0.6-0.32-0.110.21-0.420.14-0.32-0.13-0.33-0.29-0.050.240.37-0.29
0.280.04-0.06-0.29-0.25-0.2-0.030.040.16-0.2-0.08-0.17-0.320.280.280.12-0.350.860.020.820.87-0.120.45-0.080.87
0.10.01-0.19-0.180.020.32-0.210.01-0.140.32-0.12-0.17-0.110.28-0.03-0.06-0.190.180.120.170.18-0.37-0.38-0.120.21
-0.260.35-0.350.120.230.12-0.310.35-0.340.13-0.31-0.280.210.28-0.03-0.310.150.230.60.370.240.320.37-0.30.24
0.690.040.350.060.02-0.310.430.040.73-0.37-0.030.04-0.420.12-0.06-0.310.040.110.02-0.070.1-0.1-0.06-0.030.1
-0.020.46-0.030.760.60.16-0.240.460.040.16-0.33-0.350.14-0.35-0.190.150.04-0.190.5-0.09-0.20.60.19-0.33-0.21
0.19-0.060.1-0.25-0.25-0.270.12-0.060.16-0.270.07-0.17-0.320.860.180.230.11-0.19-0.120.931.00.010.60.071.0
0.090.69-0.130.560.53-0.01-0.410.69-0.01-0.01-0.64-0.21-0.130.020.120.60.020.5-0.120.04-0.120.21-0.06-0.64-0.12
0.150.170.06-0.05-0.22-0.3-0.230.170.08-0.28-0.16-0.18-0.330.820.170.37-0.07-0.090.930.040.930.090.61-0.160.92
0.17-0.070.08-0.26-0.25-0.240.12-0.070.14-0.240.08-0.21-0.290.870.180.240.1-0.21.0-0.120.93-0.010.620.081.0
-0.20.16-0.230.350.16-0.17-0.120.16-0.16-0.16-0.10.14-0.05-0.12-0.370.32-0.10.60.010.210.09-0.010.16-0.1-0.01
-0.090.130.010.12-0.110.010.020.130.00.01-0.02-0.550.240.45-0.380.37-0.060.190.6-0.060.610.620.16-0.020.6
-0.21-0.980.05-0.81-0.080.290.57-0.98-0.040.281.00.080.37-0.08-0.12-0.3-0.03-0.330.07-0.64-0.160.08-0.1-0.020.07
0.16-0.070.06-0.26-0.26-0.230.12-0.070.13-0.230.07-0.2-0.290.870.210.240.1-0.211.0-0.120.921.0-0.010.60.07
Click cells to compare fundamentals

Prothena Plc Account Relationship Matchups

Prothena Plc fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio775.59561.9910.8952.9421.1720.11
Ptb Ratio2.312.614.694.593.443.62
Days Sales Outstanding30.496.420.02370.4220.6128.75
Book Value Per Share6.844.6110.5413.1310.557.17
Free Cash Flow Yield(0.0848)(0.17)0.0421(0.0383)(0.0707)(0.0742)
Operating Cash Flow Per Share(1.33)(2.01)2.09(2.3)(2.52)(2.39)
Stock Based Compensation To Revenue28.9725.810.120.580.450.43
Capex To Depreciation0.08140.02810.08450.623.032.64
Pb Ratio2.312.614.694.593.443.62
Ev To Sales342.2236.628.0739.8914.5213.8
Free Cash Flow Per Share(1.34)(2.02)2.08(2.31)(2.57)(2.7)
Roic(0.49)(0.31)(0.59)0.14(0.19)(0.3)
Net Income Per Share(1.95)(2.78)1.51(2.47)(2.76)(2.9)
Days Of Inventory On Hand(0.49)6.59(0.0577)(3.36)(3.02)(3.17)
Payables Turnover40.9318.1922.290.738.6915.58
Sales General And Administrative To Revenue43.945.370.230.930.680.64
Research And Ddevelopement To Revenue62.4587.790.412.512.412.29
Capex To Revenue0.680.230.0028670.0086080.03080.0292
Cash Per Share9.427.413.0915.011.638.79
Pocfratio(11.92)(5.97)23.59(26.23)(14.44)(15.16)
Capex To Operating Cash Flow(0.0105)(0.002439)0.006209(0.004264)(0.021)(0.022)
Pfcf Ratio(11.8)(5.95)23.74(26.12)(14.15)(14.85)
Days Payables Outstanding8.9220.0716.37501.9442.0255.98
Income Quality0.680.721.380.930.910.6
Roe(0.28)(0.6)0.14(0.19)(0.26)(0.25)
Ev To Operating Cash Flow(5.26)(2.51)17.47(19.76)(9.91)(10.4)
Pe Ratio(8.13)(4.31)32.62(24.4)(13.15)(13.81)
Ev To Free Cash Flow(1.04)(5.2)(2.51)17.58(19.67)(10.19)
Intangibles To Total Assets(0.006449)(0.00406)(0.002219)(0.002918)(0.003356)(0.003524)
Net Debt To E B I T D A4.472.5(7.87)5.353.193.03
Current Ratio21.3611.5817.4814.3411.2422.33
Tangible Book Value Per Share6.914.6410.5713.1810.557.2
Receivables Turnover477.511.9756.87869.4417.7116.83
Graham Number17.3216.9918.9527.0125.6117.34
Shareholders Equity Per Share6.844.6110.5413.1310.557.17

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.46)
Revenue Per Share
2.482
Quarterly Revenue Growth
(0.99)
Return On Assets
(0.16)
Return On Equity
(0.23)
The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.